CH650148A5 - Composition pharmaceutique accelerant la guerison de blessures. - Google Patents
Composition pharmaceutique accelerant la guerison de blessures. Download PDFInfo
- Publication number
- CH650148A5 CH650148A5 CH5691/81A CH569181A CH650148A5 CH 650148 A5 CH650148 A5 CH 650148A5 CH 5691/81 A CH5691/81 A CH 5691/81A CH 569181 A CH569181 A CH 569181A CH 650148 A5 CH650148 A5 CH 650148A5
- Authority
- CH
- Switzerland
- Prior art keywords
- amino acids
- composition according
- composition
- gel
- isoleucine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
- A61L2300/214—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8028554 | 1980-09-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH650148A5 true CH650148A5 (fr) | 1985-07-15 |
Family
ID=10515840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH5691/81A CH650148A5 (fr) | 1980-09-04 | 1981-09-03 | Composition pharmaceutique accelerant la guerison de blessures. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0047647B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS5780316A (cg-RX-API-DMAC7.html) |
| AU (1) | AU7486081A (cg-RX-API-DMAC7.html) |
| BE (1) | BE890230A (cg-RX-API-DMAC7.html) |
| CA (1) | CA1198679A (cg-RX-API-DMAC7.html) |
| CH (1) | CH650148A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE3173310D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK390181A (cg-RX-API-DMAC7.html) |
| ES (1) | ES505172A0 (cg-RX-API-DMAC7.html) |
| FI (1) | FI812708A7 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2489145A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2082911B (cg-RX-API-DMAC7.html) |
| IT (1) | IT1209894B (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ198259A (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA816124B (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE82511T1 (de) * | 1982-04-22 | 1992-12-15 | Squibb & Sons Inc | Granulate zur verwendung bei der behandlung von wunden. |
| DE3376957D1 (en) * | 1982-06-24 | 1988-07-14 | Robert Alan Smith | Pharmaceutical gel composition |
| GR79380B (cg-RX-API-DMAC7.html) * | 1982-09-28 | 1984-10-22 | Johnson & Johnson Prod Inc | |
| AU3298184A (en) * | 1983-09-13 | 1986-09-11 | Ed Giestlich Sohne A.G. Fur Chemische Industrie | Topically administrable pharmaceutical compositions |
| DD248961A1 (de) * | 1984-05-22 | 1987-08-26 | Akad Wissenschaften Ddr | Verfahren zur herstellung wundheilungsfoerdernder praeparationen |
| EP0274532B1 (en) * | 1986-06-13 | 1992-09-09 | Japan Immuno Research Laboratories Co., Ltd. | Wound-healing drug and cosmetics |
| EP0321709A3 (en) * | 1987-12-23 | 1990-04-04 | Francisco José Izundegui MacDonnell | Fast healing and binding chemical compound or curative agent for healing wounded live animal and human soft tissues inflicted by cutting edges or separating forces |
| US4871718A (en) * | 1987-12-29 | 1989-10-03 | Raymond A. Roncari | Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
| GB2276819B (en) * | 1993-03-23 | 1996-12-11 | Johnson & Johnson Medical | Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol |
| US5670169A (en) * | 1993-12-20 | 1997-09-23 | E.R. Squibb & Sons, Inc. | Wound hydrating gel with novel preservative system and low cytotoxicity |
| GB2291348B (en) * | 1994-07-18 | 1999-01-20 | Johnson & Johnson Medical | Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol |
| WO1998043613A1 (en) * | 1997-04-02 | 1998-10-08 | Tamaz Shalvovich Mchedlidze | Ointments for treating suppurative lesions, burns and trophic ulcers at all stages, preparation and applications of same |
| RU2165754C2 (ru) * | 1997-04-02 | 2001-04-27 | Мчедлидзе Тамаз Шалвович | Мазь для лечения гнойновоспалительных заболеваний, ожогов, воспалительных заболеваний суставов, трофических язв и длительно незаживающих ран, способ ее приготовления и способ лечения |
| RU2138250C1 (ru) * | 1997-06-23 | 1999-09-27 | ОАО "Нижегородский химико-фармацевтический завод" | Способ получения мази "диоксиколь" |
| RU2146923C1 (ru) * | 1997-11-05 | 2000-03-27 | Рязанский областной клинический кожно-венерологический диспансер | Средство для лечения дерматозов |
| RU2146921C1 (ru) * | 1997-11-05 | 2000-03-27 | Рязанский областной клинический кожно-венерологический диспансер | Мазевая композиция, стимулирующая регенерацию эпителия |
| RU2145497C1 (ru) * | 1998-04-16 | 2000-02-20 | Государственный научный центр лекарственных средств | Средство для лечения гнойно-некротических процессов |
| RU2135180C1 (ru) * | 1999-02-15 | 1999-08-27 | Фармацевтическое научно-производственное предприятие "Ретиноиды" (акционерное общество закрытого типа) | Мазь для заживления ран |
| WO2001034214A1 (en) | 1999-11-09 | 2001-05-17 | Denki Kagaku Kogyo Kabushiki Kaisha | Use of soluble cellulose derivative having been made hardly soluble in water and process for producing the same |
| WO2002094256A1 (en) * | 2001-05-23 | 2002-11-28 | Debatosh Datta | Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis |
| RU2349302C1 (ru) * | 2007-09-21 | 2009-03-20 | Виталий Георгиевич Пшеничников | Фармацевтическая композиция для наружного применения "офломелид" при гнойно-воспалительных заболеваниях |
| US10413528B2 (en) * | 2014-10-20 | 2019-09-17 | John H. Plumb | Methods to inhibit infection during wound healing with topical compositions including amino acids |
| JP2020531006A (ja) | 2017-08-18 | 2020-11-05 | カルウッド ニュートリショナルズ，エルエルーシー | 筋量および体力を増大させ、肌を処置し、加齢および暴露からの傷みおよび衰えを縮減し、運動および外傷などのストレスからの回復を改善するための組成物および方法 |
| RU2733714C2 (ru) * | 2017-11-07 | 2020-10-06 | Общество с ограниченной ответственностью "Трейдсервис" | Стабильная комбинированная фармацевтическая композиция диоксидина и анестетиков |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3786076A (en) * | 1966-10-13 | 1974-01-15 | J Morelle | Lipoaminoacids |
| FR2215212B1 (cg-RX-API-DMAC7.html) * | 1973-01-18 | 1976-03-05 | Seperic Ch | |
| DE2438703C3 (de) * | 1974-08-12 | 1980-02-21 | Ernst Dr.Med. 4970 Bad Oeynhausen Lauven | Verwendung einer Mischung bei der Rheumabehandlung |
-
1981
- 1981-09-01 FR FR8116636A patent/FR2489145A1/fr active Granted
- 1981-09-02 FI FI812708A patent/FI812708A7/fi not_active Application Discontinuation
- 1981-09-02 AU AU74860/81A patent/AU7486081A/en not_active Abandoned
- 1981-09-03 CH CH5691/81A patent/CH650148A5/fr not_active IP Right Cessation
- 1981-09-03 IT IT8149222A patent/IT1209894B/it active
- 1981-09-03 NZ NZ198259A patent/NZ198259A/xx unknown
- 1981-09-03 JP JP56137858A patent/JPS5780316A/ja active Pending
- 1981-09-03 ZA ZA816124A patent/ZA816124B/xx unknown
- 1981-09-03 DK DK390181A patent/DK390181A/da not_active Application Discontinuation
- 1981-09-03 CA CA000385170A patent/CA1198679A/en not_active Expired
- 1981-09-03 ES ES505172A patent/ES505172A0/es active Granted
- 1981-09-04 BE BE0/205872A patent/BE890230A/fr not_active IP Right Cessation
- 1981-09-04 DE DE8181304053T patent/DE3173310D1/de not_active Expired
- 1981-09-04 GB GB8126836A patent/GB2082911B/en not_active Expired
- 1981-09-04 EP EP81304053A patent/EP0047647B1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES8307491A1 (es) | 1983-07-01 |
| IT8149222A0 (it) | 1981-09-03 |
| EP0047647A3 (en) | 1982-09-15 |
| BE890230A (fr) | 1982-01-04 |
| DK390181A (da) | 1982-03-05 |
| AU7486081A (en) | 1982-03-11 |
| GB2082911B (en) | 1984-04-18 |
| ZA816124B (en) | 1982-09-29 |
| FR2489145B1 (cg-RX-API-DMAC7.html) | 1984-05-25 |
| DE3173310D1 (en) | 1986-02-06 |
| EP0047647B1 (en) | 1985-12-27 |
| FI812708L (fi) | 1982-03-05 |
| JPS5780316A (en) | 1982-05-19 |
| GB2082911A (en) | 1982-03-17 |
| EP0047647A2 (en) | 1982-03-17 |
| NZ198259A (en) | 1985-05-31 |
| CA1198679A (en) | 1985-12-31 |
| ES505172A0 (es) | 1983-07-01 |
| IT1209894B (it) | 1989-08-30 |
| FR2489145A1 (fr) | 1982-03-05 |
| FI812708A7 (fi) | 1982-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH650148A5 (fr) | Composition pharmaceutique accelerant la guerison de blessures. | |
| CA1330307C (fr) | Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol | |
| JP2728134B2 (ja) | 非経口栄養サポート用アミノ酸組成物 | |
| EP0233429B1 (fr) | Composition pharmaceutique contenant une association de collagène et d'un principe actif antiseptique et/ou anti-inflammatoire et son procédé de fabrication | |
| FR3035790A3 (fr) | Preparation dentaire a base d'hyaluronane et de dichlorhydrate d'octenidine | |
| WO2003030926A1 (en) | Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom | |
| US9782458B2 (en) | Composition for tissue/cell repair | |
| RU2691647C1 (ru) | Средство для профилактики образования патологических кожных рубцов | |
| RU2080871C1 (ru) | Средство, обладающее регенеративной активностью | |
| US20230082131A1 (en) | Compositions including amelogenin and uses thereof | |
| FR2729568A1 (fr) | Composition a base d'argile verte pour applications ou enveloppements corporels | |
| JPH07267855A (ja) | グルタミン産生剤 | |
| RU2640930C1 (ru) | Способ лечения красного плоского лишая в полости рта | |
| TW200538150A (en) | Encapsulated peptide copper complexes and compositions and methods related thereto | |
| RU2750376C1 (ru) | Способ получения иммобилизованного ферментного препарата на основе трипсина, гиалуроновой кислоты и полисахаридов, модифицированных виниловыми мономерами | |
| TWI754324B (zh) | 促進血管增生之短鏈胜肽組合物及其於糖尿病傷口癒合之用途 | |
| RU2744457C1 (ru) | Способ получения иммобилизованного ферментного препарата на основе фицина, гиалуроновой кислоты и полисахаридов, модифицированных виниловыми мономерами | |
| US20250195567A1 (en) | Compositions for removing microbial biofilm or inhibiting formation thereof | |
| CN114057831B (zh) | 促进血管增生的短链胜肽及其促进糖尿病伤口愈合的用途 | |
| WO2019080983A1 (fr) | Nouvelle formulation a base de chitosane et son procede de preparation. | |
| CN1515315A (zh) | 一种含表皮生长因子和白及的稳定组合物 | |
| MC1044A1 (fr) | Médicament antimicrobien | |
| WO2025132610A1 (en) | Composition comprising amino acids, metabolizable and lipid component | |
| US20230310538A1 (en) | Tissue repair and wound healing composition and method using low molecular weight hydrolyzed collagen | |
| US20250041376A1 (en) | Wound healing and tissue repair composition and method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |